Investors

Event Calendar

 

Upcoming Events

Q2 2022 Financial Results week of 01 August 2022

Read more


    Q3 2022 Financial Results week of 07 November 2022

    Read more


      Year End 2022 Financial Results week of 06 March 2023

      Read more


        Past Events

        Year End 2021 Financial Results 10th March 2022

        March 11, 2022

        Read more

        ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference

        January 13, 2022

        Read more

        ObsEva Conference Call and Webcast 6th January

        January 6, 2022

        Read more
        1 2 3 4 30

        General Meetings

        ObsEva Annual General Meeting 2022

        May 18, 2022

        Read more

        ObsEva Annual General Meeting 2021

        May 28, 2021

        Read more
        1 2 3 4
         
         

        Sign up for news

         
         

          * Type:


          InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther












          Read our privacy policy here.


           

          Are you sure you want to leave ObsEva.com?

          We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

          Continue to link

          Disclaimer

          Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

          Continue

          Disclaimer

          Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

          Continue